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Abstract: To relate structural (anatomical) and functional (behavioral) 
measures of glaucomatous damage, a method is described for comparing 
visual field defects to local retinal ganglion cell (RGC) and retinal nerve 
fiber layer (RNFL) thicknesses. Thickness maps of the RNFL and the RGC 
+ inner plexiform layer, obtained with frequency domain optical coherence 
tomography (fdOCT), were transformed into probability maps by 
comparing them to a normative group. As demonstrated in patients with 
glaucomatous damage to the macula, the probability map associated with 
the patient’s visual field can be directly compared to the fdOCT probability 
maps by taking into consideration the displacement of the RGCs. 
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1. Introduction 
Glaucoma is a progressive optic neuropathy that damages the retinal ganglion cells (RGC) and 
their axons. To diagnose and follow glaucoma, visual fields are typically obtained in addition 
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(C) 2011 OSA 1 May 2011 / Vol. 2,  No. 5 / BIOMEDICAL OPTICS EXPRESS  1097to fundus examinations. These visual fields, usually obtained with standard automated 
perimetry (SAP), have the advantage of providing a topographical spatial representation of the 
visual loss, which can be compared to characteristic patterns of glaucomatous loss. Today 
many clinicians augment this information with images from optical coherence tomography 
(OCT). 
OCT is a non-invasive test that employs near-infrared light in much the same way that 
ultrasound uses sound [1,2]. With the newer frequency domain (fd) OCT, it is possible to 
measure the thickness of the two layers damaged by glaucoma, the retinal nerve fiber layer 
(RNFL), which contains the axons of the RGCs, and the RGC plus the inner plexiform layer 
(IPL), which contains the RGC bodies as well as the connections of the cells of the inner 
nuclear layer to these RGCs (e.g., [3–7]). 
While numerous studies have documented the efficacy of the fdOCT in detecting 
glaucomatous damage, it is still not clear how best to combine fdOCT information with SAP 
visual field data. One can always ask whether each is normal or not, but this does not take 
advantage of the spatial information available on the fdOCT tests. For example, if the 
abnormal regions on both tests match, one would have more confidence in a diagnosis of 
glaucoma than if different regions were abnormal on each test. Our purpose here is to describe 
a method for comparing spatially local visual field defects to local RGC + IPL and RNFL 
thicknesses. We illustrate this method by applying it to patients with glaucomatous damage to 
the macula. 
2. Methods 
2.1. Subjects 
Macular and disc 6mm x 6mm cube scans (Topcon, Inc, Paramus, NJ) were obtained from 
healthy controls and patients. The normative group (39 ± 14 yrs) consisted of 128 eyes from 
128 controls (data supplied by Topcon, Inc.). To be included, subjects were required to have a 
correction between + 3.0D and 6.0D, IOP  21 mmHg, axial length between 22 and 26 mm, 
a normal clinical exam, and normal visual fields (SITA Standard, Carl Zeiss Meditec, Inc, 
Dublin, CA; reliability indices all  33%). Exclusion criteria included history of ocular 
disease or a family history of glaucoma. The patient group (58 ± 14 yrs) consisted of 16 eyes 
(12 patients) with glaucomatous optic neuropathy, based on a clinical fundus examination. All 
patients also underwent 24-2 and 10-2 visual field testing. They were selected from a larger 
group of patients based upon a normal 24-2 visual field outside the central 10° [8]. In 
particular, eyes were excluded if their 24-2 test had a cluster of 3 contiguous points (5%, 5%, 
1%) within a hemifield, but outside the central 10°. The total deviation plots were used for all 
visual field analyzes. 
Written informed consent was obtained from all subjects. Procedures followed the tenets 
of the Declaration of Helsinki, and the protocol was approved by the Committee of the 
Institutional Board of Research of Columbia University. 
2.2. OCT analysis 
Using an automated segmentation algorithm [9], three borders were defined: the 
vitreous/RNFL, RNFL/RGC, and IPL/inner nuclear layer borders (Fig. 1A). An experienced 
operator hand-corrected the automatic segmentation of the combined RGC and inner 
plexiform layers (RGC + IPL) of 128 horizontal B-scans for each cube scan. From these 
segmented lines, RNFL and RGC + IPL thicknesses were obtained as shown by the red (RGC 
+ IPL) and green (RNFL) bars in Fig. 1. The thickness measures were then smoothed in two 
dimensions for the 6 by 6 mm (20° by 20°) area of interest with a two-dimensional averaging 
filter using a window size of about 80 μm. For each cube scan, thickness maps as in the left 
column of Fig. 1 were obtained. There were 3 such maps: macular RGC + IPL thickness, 
macular RNFL thickness, and optic disc RNFL thickness. The thicknesses corresponding to 
the pseudo-colors are shown on the calibration bars in this figure. Note that a RGC + IPL 
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the RGC layer is in this region, it does not add to the analysis. 
 
Fig. 1. Sample thickness maps and scans from a healthy control. A. RGC + IPL thickness map 
(left) and a scan through the horizontal meridian with the segmentation displayed in light blue 
(right). B. RNFL thickness map (left) and a scan through the horizontal meridian (right). C. 
RNFL thickness map (left) and a scan through the center of the optic disc (right). 
3. Results 
3.1. The method 
Figure 1A (left panel) shows a pseudo-color representation of the RGC + IPL thickness of a 
healthy control based upon the macular cube scan. As expected, the greatest RGC + IPL 
thickness is just outside the foveal center at about 4°. By around 10°, the thickness is reaching 
an asymptotic level. 
In contrast, the RNFL thickness derived from the same cube scan (Fig. 1B, left panel) 
shows a different pattern. As expected, the RNFL is relatively thin except in the arcuate 
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depicts the thickness of the RNFL for the optic disc, cube scan. Because the macular and optic 
disc cube scans provide overlapping information about RNFL thickness, they were combined 
into one map as in Fig. 2A by co-registration based upon blood vessel alignment in an en face 
view of the fdOCT scan. The same maps are shown in Fig. 2B with iso-thickness contours 
added, while Fig. 2C shows the RGC + IPL map in the same format. Note that both maps 
were flipped across the horizontal axis so as to be presented in the same way as the visual 
field. Additionally, the results for left eyes were flipped across the vertical axis so that all eyes 
were presented as right eyes in all figures. 
 
Fig. 2. RGC + IPL and RNFL thickness maps for the control in Fig. 1A. Combined RNFL 
thickness maps from scans of the macula and optic disc. B. Same scans as in A shown with iso-
thickness contours and after flipping across the horizontal axis to present in field view. C. 
Same as in B for RGC + IPL thickness. 
Figure 3A presents the 24-2 and 10-2 visual fields and the 3 thickness maps illustrated in 
Fig. 1 for the healthy control in Fig. 1. The red circles have a radius of 10°. Figures 3B-D 
show the results from 3 patients. (Note that in all figures, the OCT results are flipped along 
the horizontal axis to coincide with the field view.) Patients 1 and 2 have clear arcuate defects 
that can be seen on the 10-2 and all three OCT thickness maps. Patient 3’s visual field damage 
is more subtle, although again there appears to be an indication of an upper field arcuate 
defect that appears to be confirmed on the OCT maps (red arrows). However, we cannot tell if 
the cluster of abnormal points on the visual field (green arrow) corresponds to the region that 
appears thinned (red arrows) in the OCT scans. In particular, is the RGC + IPL thinning in the 
same place as the abnormal points on the 10-2 (green arrow); and, does the OCT thinning 
reach statistical significance? 
To address the first question, we need a way to relate the location of the visual field points 
to the region of the RGCs activated by these points. To make this comparison, we must take 
into consideration the displacement of the RGCs near the fovea. That is, light falling on 
receptors near the foveal center excite RGCs that are some distance from this location. As  
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Fig. 3. Sample visual fields and OCT thickness maps. A. 24-2 (left panel) and 10-2 (second 
column) visual fields are shown for a healthy control along with the thickness maps for the 
macula RGC + IPL (middle panel) and RNFL thickness (fourth panel), and the optic disc 
RNFL thickness (right panel). B,C,D. Same as in A for 3 patients. 
previously reported [5,8], we can use the results of Drasdo et al. [10] to locate the average 
location of the excited RGCs for each of the visual field points. Note, this does not take into 
consideration any variation in RGC displacement that may occur from one individual to 
another. Figure 4A shows the thickness maps for patient 1 presented as in Figs. 2B,C. In Fig. 
4B, the superimposed small circles show the retinal location of the RGCs associated with the 
10-2 (small circles) test locations. 
To address the second question, the OCT thickness maps need to be transformed into 
probability maps. To do this, the local OCT thickness for an individual is compared to the 
distribution of thicknesses of the 128 healthy control eyes. The maps in Fig. 4C show the 
results as a continuous probability scale. This scale is shown in the middle of this panel, 
where dark green indicates a p value of greater than 10%, yellow 5%, red about 1% and dark 
red <1%. 
The final step involves combining the probability information from the visual fields and 
the OCT images. Figure 5A shows the combined OCT/10-2 probability maps for patient 1. 
The significantly abnormal points from this patient’s 10-2 visual field (Fig. 3B, second 
column) are shown as the yellow (5%) and red (<1%) circles. It is easy to see the agreement 
between the probability maps for the 10-2 and OCT thicknesses. 
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Fig. 4. RGC + IPL and RNFL maps for patient 1. A. OCT thickness maps as in Figs. 2B, C. B. 
Maps from panel A with 10-2 test locations displaced based upon displacement of RGCs. C. 
Probability maps for OCT thickness. 
Figures 5B,C show the combined OCT/10-2 probability maps for the other 2 patients in 
Fig. 3. The combined probability maps (Fig. 5B) for patient 2 resemble those for patient 1. 
For patient 3, while the visual fields suggest that the damage is relatively confined and subtle, 
the RGC + IPL probability map suggests more extensive damage. 
3.2. Patient data 
The 10-2 visual fields of the 16 patient eyes were classified as arcuate or partial arcuate (8), 
diffuse (1), and normal (7). Figures 3B-D shows the field and OCT data for 3 of the 8 patients 
with arcuate or partial arcuate visual fields. The combined OCT/10-2 probability maps for 
these 3 patients are shown in Fig. 5. For all 8 arcuate visual fields, the RGC + IPL and RNFL 
probability maps showed arcuate damage in the same region in which the visual field 
contained abnormal points. In six cases, both the significantly abnormal portions of the OCT 
and fields coincided as seen for Patients 1 and 2 (Figs. 5A,B). In two eyes (same patient), the 
OCT abnormal region included both hemifields, while the visual field showed abnormalities 
only in the superior field (Fig. 5C). For the eye with the diffuse visual field, the OCT 
probability map showed damage in both hemispheres. 
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Fig. 5. A-C. Combined OCT/10-2 probability maps for the 3 patients from Fig. 3. 
Five of the 7 eyes with 10-2 visual fields classified as normal had OCT probability maps 
within the normal range. The other 2 are of particular interest. In one case, Patient 4, there 
were abnormal points in the upper field of the 10-2 (Fig. 6C), although the visual field was 
normal based upon MD, PSD and cluster criteria. Of note is that the combined OCT/10-2 
maps (Figs. 6A,B) showed evidence of an arcuate defect in both hemispheres. Figure 7 shows 
the results for Patient 5 (OD), the 7th eye with a normal visual field. Note the arcuate damage 
on the OCT corresponding to a lower field arcuate defect. The 10-2 Total Deviation plot did 
not show a single abnormal point (Fig. 7C). In fact, these points were nearly all positive (more 
sensitive than normal), as if this patient had a higher baseline sensitivity or lower criterion for 
saying “I see it”. In any case, the Pattern Deviation map (Fig. 7D), although normal based 
upon MD and PSD criteria, showed significantly abnormal points in the region corresponding 
to the lower field arcuate seen on the OCT maps. 
3.3. Future directions 
There are a number of possible improvements that can be made to this approach. First, if 10-2 
visual field data were available on a large group of healthy controls, then the visual field data 
could be referenced to the same continuous probability scale used for the OCT data. Second, 
summary statistics can be generated for the OCT maps analogous to the mean deviation, 
pattern standard deviation and glaucoma hemifield test of the visual field tests. In addition,  
 
#143101 - $15.00 USD Received 25 Feb 2011; revised 28 Mar 2011; accepted 28 Mar 2011; published 5 Apr 2011
(C) 2011 OSA 1 May 2011 / Vol. 2,  No. 5 / BIOMEDICAL OPTICS EXPRESS  1103 
Fig. 6. Results for patient 4. A.B. Combined OCT/10-2 probability maps. C. 10-2 Total 
Deviation map. 
 
Fig. 7. Results for patient 5. A, B. Combined OCT/10-2 probability maps. C. 10-2 Total 
Deviation map. D. 10-2 Pattern Deviation map. 
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visual evoked potential reports [11]. 
4. Conclusion 
Combined visual field and OCT probability maps make it easy to compare structural and 
functional measures of glaucomatous damage. These combined maps should improve the 
diagnosis of glaucoma. Further, as the variance in OCT and visual fields measures should be 
independent, the visual field and OCT probabilities can be mathematically combined to 
improve the sensitivity/specificity of these tests. 
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